跳转至内容
Merck
CN

A2795

Sigma-Aldrich

N-乙酰-d-半乳糖胺

≥98% (HPLC)

别名:

2-乙酰氨基-2-脱氧-D-半乳糖, D-GalNAc, N-乙酰半乳糖胺

登录查看公司和协议定价


About This Item

经验公式(希尔记法):
C8H15NO6
CAS号:
分子量:
221.21
Beilstein:
2331340
EC 号:
MDL编号:
UNSPSC代码:
12352201
PubChem化学物质编号:
NACRES:
NA.25

质量水平

方案

≥98% (HPLC)

表单

powder

技术

HPLC: suitable

颜色

white

mp

160 °C

溶解性

water: 50 mg/mL, clear, colorless

储存温度

2-8°C

SMILES字符串

CC(=O)N[C@H]1C(O)O[C@H](CO)[C@H](O)[C@@H]1O

InChI

1S/C8H15NO6/c1-3(11)9-5-7(13)6(12)4(2-10)15-8(5)14/h4-8,10,12-14H,2H2,1H3,(H,9,11)/t4-,5-,6+,7-,8?/m1/s1

InChI key

OVRNDRQMDRJTHS-KEWYIRBNSA-N

正在寻找类似产品? 访问 产品对比指南

一般描述

N-乙酰-D-半乳糖胺 (GalNAc) 是一种氨基糖,是许多 O-连接和N-连接聚糖结构的组成部分。作为尿苷二磷酸 (UDP)-GalNAc,GalNAc是许多丝氨酸和苏氨酸残基蛋白质糖基化的初始O连接糖。

应用

N-乙酰-D-半乳糖胺已用于:
  • 用作双花扁豆凝集素 (DBA) 半抗原糖,用于凝集素珠结合测定
  • 通过凝集素印迹抑制评估凝集素结合的特异性
  • 免疫组织化学预吸附紫藤凝集素

N-乙酰-D-半乳糖胺(GalNAc)是一种氨基糖,是许多O-连接和N连接聚糖结构的组分。 作为UDP-GalNAc,GalNAc是许多蛋白质糖基化丝氨酸和苏氨酸残基的起始O-连接糖。

其他说明

为了全面了解我们针对客户研究提供的各种单糖产品,建议您访问我们的碳水化合物分类页面。

储存分类代码

11 - Combustible Solids

WGK

WGK 3

闪点(°F)

Not applicable

闪点(°C)

Not applicable

个人防护装备

Eyeshields, Gloves, type N95 (US)


从最新的版本中选择一种:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Malte Lenders et al.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 32(12), 2090-2097 (2016-09-30)
Renal and cardiac involvement is responsible for substantial morbidity and mortality in Fabry disease (FD). We analysed the incidence of FD-related renal, cardiac and neurologic end points in patients with FD on long-term enzyme replacement therapy (ERT). A retrospective analysis
Yuki Kuramoto et al.
Journal of molecular and cellular cardiology, 121, 256-265 (2018-07-27)
Fabry disease is an X-linked disease caused by mutations in α-galactosidase A (GLA); these mutations result in the accumulation of its substrates, mainly globotriaosylceramide (Gb3). The accumulation of glycosphingolipids induces pathogenic changes in various organs, including the heart, and Fabry
P Van den Steen et al.
Critical reviews in biochemistry and molecular biology, 33(3), 151-208 (1998-07-23)
The biosynthesis, structures, and functions of O-glycosylation, as a complex posttranslational event, is reviewed and compared for the various types of O-glycans. Mucin-type O-glycosylation is initiated by tissue-specific addition of a GalNAc-residue to a serine or a threonine of the
F H M van Zelst et al.
Faraday discussions, 218(0), 219-232 (2019-05-24)
To detect and characterise compounds in complex matrices, it is often necessary to separate the compound of interest from the matrix before analysis. In our previous work, we have developed the coupling of supercritical fluid chromatography (SFC) with nuclear magnetic
Kai J Rogers et al.
PLoS neglected tropical diseases, 13(12), e0007819-e0007819 (2019-12-12)
Ebolavirus (EBOV) outbreaks, while sporadic, cause tremendous morbidity and mortality. No therapeutics or vaccines are currently licensed; however, a vaccine has shown promise in clinical trials. A critical step towards development of effective therapeutics is a better understanding of factors

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门